[HTML][HTML] Autoantibody production in cancer—the humoral immune response toward autologous antigens in cancer patients
A link between autoimmune responses and cancer via autoantibodies was first described in
the 1950s. Since, autoantibodies have been studied for their potential use as cancer …
the 1950s. Since, autoantibodies have been studied for their potential use as cancer …
[HTML][HTML] Prognostic value of HLA-I homozygosity in patients with non-small cell lung cancer treated with single agent immunotherapy
Background We aimed to assess the impact of genomic human leukocyte antigen (HLA)-I/II
homozygosity on the survival benefit of patients with unresectable locally advanced …
homozygosity on the survival benefit of patients with unresectable locally advanced …
[HTML][HTML] Detection and prognostic role of heterogeneous populations of melanoma circulating tumour cells
Abstract Background Circulating tumour cells (CTCs) can be assessed through a minimally
invasive blood sample with potential utility as a predictive, prognostic and …
invasive blood sample with potential utility as a predictive, prognostic and …
[HTML][HTML] Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype B
Background A Phase I clinical trial has been proposed that uses neutralising monoclonal
antibodies (MAbs) as passive immunoprophylaxis to prevent mother-to-child transmission of …
antibodies (MAbs) as passive immunoprophylaxis to prevent mother-to-child transmission of …
[HTML][HTML] UCLA1 aptamer inhibition of human immunodeficiency virus type 1 subtype C primary isolates in macrophages and selection of resistance
We have previously shown that the aptamer, UCLA1, is able to inhibit HIV-1 replication in
peripheral blood mononuclear cells (PBMCs) by binding to residues in gp120. In this study …
peripheral blood mononuclear cells (PBMCs) by binding to residues in gp120. In this study …
Characterization of neutralizing antibody epitopes on HIV-1 subtype C envelope glycoproteins to support vaccine design
ES Gray - 2009 - wiredspace.wits.ac.za
Since its discovery as the etiological agent of AIDS in 1983, HIV-1 has been the focus of
unrelenting research into an effective vaccine to control viral infection. Neutralizing …
unrelenting research into an effective vaccine to control viral infection. Neutralizing …
[CITATION][C] Early Autologous Neutralising Epitopes in C3-V4 and β14+ V5 are readily adsorbed with monomeric gp120
CK Wibmer, JN Bhiman… - AIDS …, 2011 - MARY ANN LIEBERT INC 140 …